FZD2 and neoplasm: The study by Gujral et al. (2014) investigated the Wnt receptor Frizzled2 (Fzd2) in epithelial-mesenchymal transition, and suggested that using an antibody to Fzd2 was a novel way to inhibit tumor growth and metastasis.